Linear correlation of CRT toward time (weeks) over the course of bevacizumab therapy showed a negative trend (slope = −0.71) reflecting the overall drug’s therapeutic action.
← all excerpts
Real-World Use of Off-Label MVASI in the Treatment of Patients With Neovascular AMD and DME.
1
—
—